S Y Kim Selected Research

poly(p- dioxanone- co- L- lactide)- block- poly(ethylene glycol)

3/2007

Amphiphilic triblock copolymer poly(p-dioxanone-co-L-lactide)-block-poly(ethylene glycol), enhancement of gene expression and inhibition of lung metastasis by aerosol delivery.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S Y Kim Research Topics

Disease

43	Neoplasms (Cancer) 01/2018 - 01/2000
16	Neoplasm Metastasis (Metastasis) 01/2018 - 04/2000
9	Stomach Neoplasms (Stomach Cancer) 01/2018 - 09/2000
8	Inflammation (Inflammations) 11/2022 - 09/2001
8	Infections 01/2014 - 12/2000
7	Pain (Aches) 11/2017 - 12/2005
7	Squamous Cell Carcinoma of Head and Neck 07/2017 - 08/2000
7	Hemorrhage 07/2007 - 11/2001
6	Hepatocellular Carcinoma (Hepatoma) 12/2020 - 03/2001
6	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 06/2007
5	Aneurysm (Aneurysms) 11/2010 - 10/2000
4	Vomiting 01/2020 - 05/2002
4	Carcinoma (Carcinomatosis) 01/2018 - 09/2000
4	Acute Kidney Injury (Acute Renal Failure) 04/2016 - 10/2000
4	Ischemia 04/2015 - 05/2000
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2013 - 01/2000
4	Type 2 Diabetes Mellitus (MODY) 02/2013 - 07/2005
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2009 - 04/2007
4	Thrombocytopenia (Thrombopenia) 07/2007 - 10/2000
4	Rheumatoid Arthritis 09/2004 - 07/2000
3	Nausea 01/2020 - 05/2002
3	Breast Neoplasms (Breast Cancer) 01/2018 - 04/2001
3	Melanoma (Melanoma, Malignant) 10/2017 - 04/2001
3	Hypertension (High Blood Pressure) 07/2017 - 11/2006
3	Leukemia 05/2015 - 04/2000
3	Carcinogenesis 03/2015 - 10/2000
3	Tuberculosis (Tuberculoses) 08/2014 - 04/2012
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2010 - 12/2000
3	Insulin Resistance 07/2005 - 08/2000
2	Dementia (Dementias) 01/2020 - 10/2016
2	Disease Progression 01/2018 - 10/2017
2	Second Primary Neoplasms (Neoplasms, Second) 07/2017 - 10/2007
2	Alzheimer Disease (Alzheimer's Disease) 02/2017 - 02/2001
2	Lung Neoplasms (Lung Cancer) 01/2017 - 03/2007
2	Glucose Intolerance 01/2016 - 01/2000
2	Obesity 01/2016 - 06/2013
2	Postoperative Pain 09/2015 - 03/2011
2	Drug-Related Side Effects and Adverse Reactions 08/2015 - 01/2003
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2015 - 04/2006
2	Ovarian Neoplasms (Ovarian Cancer) 01/2014 - 10/2010
2	Hypoxia (Hypoxemia) 08/2013 - 07/2012
2	Lymphatic Metastasis 08/2013 - 03/2013
2	Reperfusion Injury 07/2013 - 11/2001
2	Respiratory Hypersensitivity 04/2013 - 11/2007
2	Latent Tuberculosis 02/2013 - 12/2012
2	Stroke (Strokes) 11/2010 - 10/2001

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2018 - 04/2000
8	Biomarkers (Surrogate Marker)IBA 01/2018 - 02/2010
7	Insulin (Novolin)FDA Link 04/2014 - 03/2000
7	DNA (Deoxyribonucleic Acid)IBA 04/2012 - 01/2000
6	Pharmaceutical PreparationsIBA 01/2022 - 01/2000
6	CytokinesIBA 01/2021 - 03/2006
6	Messenger RNA (mRNA)IBA 01/2018 - 09/2000
5	Fentanyl (Sublimaze)FDA LinkGeneric 01/2020 - 12/2005
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2013 - 07/2001
5	Glucose (Dextrose)FDA LinkGeneric 02/2007 - 01/2000
4	SteroidsIBA 01/2022 - 09/2000
4	C-Reactive ProteinIBA 11/2019 - 03/2006
4	RNA (Ribonucleic Acid)IBA 12/2017 - 11/2001
4	LigandsIBA 03/2015 - 03/2001
4	AnticoagulantsIBA 07/2007 - 04/2007
3	Analgesics (Analgesic Drugs)IBA 03/2016 - 01/2001
3	Oxygen (Dioxygen)IBA 07/2012 - 01/2000
3	Codon (Codons)IBA 10/2011 - 02/2001
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2006 - 09/2004
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2006 - 01/2000
3	Insulin-Like Growth Factor I (IGF-1)IBA 01/2001 - 03/2000
2	Antirheumatic Agents (DMARD)IBA 01/2022 - 03/2000
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018 - 09/2013
2	IntegrinsIBA 01/2018 - 08/2015
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2018 - 03/2006
2	OvalbuminIBA 01/2018 - 11/2007
2	InterleukinsIBA 02/2017 - 10/2007
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017 - 03/2001
2	Nuclear Proteins (Protein, Nuclear)IBA 01/2017 - 03/2006
2	Phosphotransferases (Kinase)IBA 04/2015 - 04/2006
2	AlbuminsIBA 03/2015 - 09/2000
2	Insulin-Like Growth Factor Binding Protein 3IBA 03/2015 - 01/2001
2	Insulin-Like PeptidesIBA 03/2015 - 01/2001
2	Intravenous Immunoglobulins (IVIG)FDA Link 02/2015 - 01/2001
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2015 - 01/2001
2	CreatinineIBA 10/2013 - 11/2001
2	Small Interfering RNA (siRNA)IBA 02/2013 - 09/2009
2	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 02/2013 - 01/2001
2	InterferonsIBA 02/2013 - 12/2000
2	Interleukin-2 (IL2)IBA 12/2012 - 10/2010
2	Interleukin-13IBA 12/2012 - 11/2007
2	Phospholipids (Phosphatides)FDA LinkGeneric 10/2012 - 04/2001
2	EnzymesIBA 10/2012 - 04/2012
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 10/2011 - 01/2004

Therapy/Procedure

14	Therapeutics 01/2018 - 01/2000
6	Radiotherapy 12/2020 - 04/2000
6	Aftercare (After-Treatment) 11/2017 - 10/2007
6	Drug Therapy (Chemotherapy) 06/2014 - 04/2001
6	Stents 11/2010 - 10/2000
4	Kidney Transplantation 09/2015 - 02/2013
2	Radiofrequency Ablation 12/2020 - 01/2016
2	Patient-Controlled Analgesia (Analgesia, Patient Controlled) 01/2020 - 09/2015
2	Activities of Daily Living (ADL) 10/2016 - 07/2001
2	Chemoradiotherapy 06/2012 - 07/2009